Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-29 5:24 pm Sale | 2022-12-29 | 13G | Xilio Therapeutics, Inc. XLO | Deerfield Mgmt, L.P. | 0 0.000% | -2,154,061 (Position Closed) | Filing History |
| 2022-12-23 3:35 pm Purchase | 2022-12-23 | 13G | Terns Pharmaceuticals, Inc. TERN | Deerfield Mgmt, L.P. | 2,851,287 5.940% | 991,287 (+53.30%) | Filing History |
| 2022-12-21 7:05 pm Purchase | 2022-12-19 | 13D | Oncorus, Inc. ONCR | Deerfield Mgmt, L.P. | 3,006,933 11.580% | 157,963 (+5.54%) | Filing History |
| 2022-12-01 4:51 pm Sale | 2022-11-22 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | Deerfield Mgmt, L.P. | 0 0.000% | -2,572,986 (Position Closed) | Filing History |
| 2022-11-23 3:19 pm Unchanged | 2022-11-21 | 13D | Graybug Vision, Inc. GRAY | Deerfield Mgmt, L.P. | 377,265 24.490% | 0 (Unchanged) | Filing History |
| 2022-11-18 5:06 pm Purchase | 2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY | Deerfield Mgmt, L.P. | 11,077,927 11.810% | 11,077,927 (New Position) | Filing History |
| 2022-11-18 4:14 pm Purchase | 2022-11-08 | 13G | Rain Enhancement Technologies Holdco Inc RAIN | Deerfield Mgmt, L.P. | 2,796,261 9.990% | 2,796,261 (New Position) | Filing History |
| 2022-11-17 4:38 pm Purchase | 2022-11-16 | 13G | Brookdale Senior Living Inc. BKD | Deerfield Mgmt, L.P. | 12,216,561 6.540% | 7,941,753 (+185.78%) | Filing History |
| 2022-11-16 4:47 pm Purchase | 2022-11-07 | 13G | Abeona Therapeutics Inc. ABEO | Deerfield Mgmt, L.P. | 1,739,130 5.060% | 1,739,130 (New Position) | Filing History |
| 2022-11-14 4:45 pm Purchase | 2022-11-04 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | Deerfield Mgmt, L.P. | 6,060,491 5.820% | 6,060,491 (New Position) | Filing History |
| 2022-11-14 4:44 pm Purchase | 2022-11-02 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | Deerfield Mgmt, L.P. | 2,572,986 17.340% | 2,572,986 (New Position) | Filing History |
| 2022-11-14 4:42 pm Purchase | 2022-11-03 | 13G | Nuvalent, Inc. NUVL | Deerfield Mgmt, L.P. | 25,466,889 39.240% | 690,611 (+2.79%) | Filing History |
| 2022-10-14 4:51 pm Purchase | 2022-10-10 | 13G | Enhabit, Inc. EHAB | Deerfield Mgmt, L.P. | 2,846,000 5.740% | 2,846,000 (New Position) | Filing History |
| 2022-10-04 4:32 pm Purchase | 2022-10-03 | 13G | IVERIC bio, Inc. ISEE | Deerfield Mgmt, L.P. | 6,601,000 5.590% | 1,839,862 (+38.64%) | Filing History |
| 2022-09-30 3:29 pm Purchase | 2022-09-20 | 13G | Merus N.V. MRUS | Deerfield Mgmt, L.P. | 2,521,553 5.500% | 2,521,553 (New Position) | Filing History |
| 2022-09-23 5:15 pm Purchase | 2022-09-22 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Deerfield Mgmt, L.P. | 2,414,897 5.810% | 2,414,897 (New Position) | Filing History |
| 2022-09-16 5:19 pm Purchase | 2022-09-16 | 13D | Larimar Therapeutics, Inc. LRMR | Deerfield Mgmt, L.P. | 16,963,029 42.450% | 11,126,786 (+190.65%) | Filing History |
| 2022-09-12 5:23 pm Sale | 2022-09-08 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Deerfield Mgmt, L.P. | 2,032,335 5.530% | -1,250,577 (-38.09%) | Filing History |
| 2022-08-17 1:11 pm Purchase | 2022-08-17 | 13G | GeneDx Holdings Corp. WGS | Deerfield Mgmt, L.P. | 571,166 4.950% | 147,929 (+34.95%) | Filing History |
| 2022-08-16 5:20 pm Sale | 2022-08-16 | 13G | Terns Pharmaceuticals, Inc. TERN | Deerfield Mgmt, L.P. | 1,860,000 4.940% | -485,959 (-20.71%) | Filing History |